| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/15/2011 | US7906521 Quinazoline potassium channel inhibitors |
| 03/15/2011 | CA2502769C 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 03/15/2011 | CA2490571C Pyrazoloisoquinoline derivatives for inhibiting nfkappab-inducing kinase (nik) |
| 03/15/2011 | CA2397366C Methanocarba cycloalkyl nucleoside analogues |
| 03/15/2011 | CA2379575C Pharmaceutically active sulfonamide derivatives |
| 03/15/2011 | CA2364991C Process for the preparation of perylene pigments |
| 03/10/2011 | WO2011029046A1 Bruton's tyrosine kinase inhibitors |
| 03/10/2011 | WO2011028864A1 Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer |
| 03/10/2011 | WO2011028135A1 Kinase inhibitors, prodrug forms thereof and their use in therapy |
| 03/10/2011 | WO2011027249A2 Benzimidazole derivatives |
| 03/10/2011 | WO2011027081A2 Novel derivatives of 5,6,7,8-tetrahydroindolizine inhibiting hsp90, compositions containing same, and use thereof |
| 03/10/2011 | US20110060138 Compounds and Compositions for the Detection and Treatment of Alzheimer's Disease and Related Disorders |
| 03/10/2011 | US20110060113 Switchable special effect substances |
| 03/10/2011 | US20110060004 Imidazo-Pyridine Derivatives as Activin-Like Receptor Kinase (ALK4 or ALK5) Inhibitors |
| 03/10/2011 | US20110060002 Conglomerates of tenatoprazole potassium salts |
| 03/10/2011 | US20110059999 Hydroxymethylcyclohexylamines |
| 03/10/2011 | US20110059997 SUBSTITUTED CYCLOALCANO[e AND d] PYRAZOLO [1,5-a]PYRIMIDINES/ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND METHODS FOR PRODUCTION AND THE USE THEREOF |
| 03/10/2011 | US20110059982 Azaindole compounds for treatment of central nervous system disorders |
| 03/10/2011 | US20110059977 USE OF CANTHIN-6-ONE AND ITS ANALOGS IN THE TREATMENT OF MYCOBACTERIA-LINKED PATHOLOGIES ( amended |
| 03/10/2011 | US20110059976 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 03/10/2011 | US20110059975 Non-nucleoside reverse transcriptase inhibitors |
| 03/10/2011 | US20110059964 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 03/10/2011 | US20110059961 4-substituted pyridin-3-yl-carboxamide compounds and methods of use |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |
| 03/10/2011 | US20110059955 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof |
| 03/10/2011 | US20110059954 Cgrp antagonists |
| 03/10/2011 | US20110059948 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivatives as anti-mycobacterial agents |
| 03/10/2011 | US20110059946 Dual action antibiotics |
| 03/10/2011 | US20110059943 Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer |
| 03/10/2011 | US20110059941 2-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulators |
| 03/10/2011 | US20110057177 Organic light emitting device |
| 03/10/2011 | US20110057175 Organic light emitting device |
| 03/10/2011 | CA2773038A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 03/10/2011 | CA2772616A1 Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer |
| 03/10/2011 | CA2772194A1 Benzimidazole derivatives |
| 03/10/2011 | CA2771016A1 Kinase inhibitors, prodrug forms thereof and their use in therapy |
| 03/09/2011 | EP2292629A1 Method of isolating cytisine from biomaterial |
| 03/09/2011 | EP2292620A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prohylaxis and treatment of disorders related thereto |
| 03/09/2011 | EP2292618A1 Organic light emitting device containing polycyclic heteroaryl compounds |
| 03/09/2011 | EP2292617A1 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase and/or pi3 kinase inhibitors |
| 03/09/2011 | EP2292615A1 Quinazoline compounds |
| 03/09/2011 | EP2292601A1 Phenanthro[2,3-b]pyrroles and Phenanthro[3,2-b]pyrroles for organic light-emitting devices |
| 03/09/2011 | EP2291376A2 Naphthyridininones as aurora kinase inhibitors |
| 03/09/2011 | EP2291375A1 Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
| 03/09/2011 | EP2291080A1 Novel modulators of sphingosine phosphate receptors |
| 03/09/2011 | EP2188280B1 Imidazopyridinones |
| 03/09/2011 | EP2077998B1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/09/2011 | EP1996194B1 Homotropanes with central nervous system activity |
| 03/09/2011 | EP1874770B1 Phenylacetamides suitable as protein kinase inhibitors |
| 03/09/2011 | EP1641795B1 Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals |
| 03/09/2011 | EP1497279B1 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 03/09/2011 | CN101497614B 1,2,3,5,11,11a- hexahydro-3,3-dimethyl-1-oxo-6H-glyoxaline [3', 4': 1,2] pyridine [3,4-b] diindyl-2-substituted methyl acetate, as well as preparation and application thereof |
| 03/09/2011 | CN101263130B 2-苯胺-4-芳基取代的噻唑衍生物 2-anilino-4-aryl-substituted thiazole derivative |
| 03/08/2011 | US7902375 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylin ositol 3 kinase enzymes (PI13) for treatment of inflammatory diseases |
| 03/08/2011 | US7902369 Diaryl-substituted five-membered heterocycle derivative |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7902363 Diimide-based semiconductor materials and methods of preparing and using the same |
| 03/08/2011 | US7902362 DNA threading intercalators |
| 03/08/2011 | US7902239 Diaminotriazoles useful as inhibitors of protein kinases |
| 03/08/2011 | US7902226 Dehalogeno-compounds |
| 03/08/2011 | US7902219 2-benzoylimidazopyridine derivatives, preparation and therapeutic use thereof |
| 03/08/2011 | US7902217 Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 03/08/2011 | US7902203 Polymerase inhibitors; viricides; hepatitis c virus; immunology moderator; antiinflammatory agents; cirrhosis; liver disorders |
| 03/08/2011 | US7902179 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease |
| 03/08/2011 | US7902157 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/08/2011 | US7901559 Polyacrylamide gel for electrophoresis, polyacrylamide gel electrophoresis method using the same, method of producing the same, and acrylamide compound |
| 03/08/2011 | CA2420899C Hydroxamate derivatives useful as deacetylase inhibitors |
| 03/03/2011 | WO2011025968A1 1h-pyrazolo [ 3, 4-b] pyridine compounds for inhibiting raf kinase |
| 03/03/2011 | WO2011025685A1 Jak inhibition blocks rna interference associated toxicities |
| 03/03/2011 | WO2011025006A1 Gpr119 agonist |
| 03/03/2011 | WO2011024933A1 3-(biaryloxy) propionic acid derivative |
| 03/03/2011 | WO2011024873A1 Fused heterocyclic ring derivative and use thereof |
| 03/03/2011 | WO2011024872A1 Fused heterocyclic ring derivative and use thereof |
| 03/03/2011 | WO2011024871A1 Fused heterocyclic ring derivative and use thereof |
| 03/03/2011 | WO2011024869A1 Fused heterocyclic ring derivative and use thereof |
| 03/03/2011 | WO2011024391A1 Heterocyclic compound and organic light-emitting device using the same |
| 03/03/2011 | WO2011024078A1 3 -oxopiperazinium derivatives as agonists of nerve growth factor and their use as medicaments |
| 03/03/2011 | WO2011023795A1 (thio)morpholine derivatives as s1p modulators |
| 03/03/2011 | WO2011023696A1 Methylpyrrolopyridinecarboxamides |
| 03/03/2011 | WO2011023081A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 03/03/2011 | WO2010146348A3 Crystalline form of pemirolast |
| 03/03/2011 | WO2010118711A4 Novel helquats, their precursors and method of preparation thereof |
| 03/03/2011 | WO2010002779A3 Naphthyridininones as aurora kinase inhibitors |
| 03/03/2011 | US20110053970 Spirocyclic Cyclohexane Compounds Useful To Treat Substance Dependency |
| 03/03/2011 | US20110053959 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 03/03/2011 | US20110053953 AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613 |
| 03/03/2011 | US20110053949 4-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053946 Aryl-Quinolyl Compounds and Their Use |
| 03/03/2011 | US20110053936 substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 03/03/2011 | US20110053930 Inhibitors of the bmp signaling pathway |
| 03/03/2011 | US20110053925 Hydroxamate-Based Inhibitors of Deacetylases |
| 03/03/2011 | US20110053922 Spiro (Piperidine-4,2'-Pyrrolidine)-1-(3,5-Trifluoromethyl Phenyl) Methylcarboxamides As NK1 Tachikynin Receptor Antagonists |
| 03/03/2011 | US20110053920 Substituted bicyclic pyrimidines |
| 03/03/2011 | US20110053915 HETEROCYCLIC INHIBITORS OF AN Hh-SIGNAL CASCADE, MEDICINAL COMPOSITIONS BASED THEREON AND METHODS FOR TREATING DISEASES CAUSED BY THE ABERRANT ACTIVITY OF AN Hh-SIGNAL SYSTEM |
| 03/03/2011 | US20110053911 Tricyclic derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 03/03/2011 | US20110053906 Protein kinase inhibitors and use thereof |
| 03/03/2011 | US20110053897 Compounds and compositions as syk kinase inhibitors |
| 03/03/2011 | US20110053873 Hsp90 inhibitors |
| 03/03/2011 | US20110053282 Methods and Kits Using Extended Rhodamine Dyes |
| 03/03/2011 | US20110052674 Angiotensin ii receptor blocker derivatives |